GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | 8/14/2026 5:21:09 PM | Small | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $151,010,103 | EPS -$7.17 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 6/2/2026 4:07:16 PM | View | Proxy | SEC | Y 2025 | ||||||
| Transcode Therapeutics, Inc. (RNAZ) | 5/15/2026 4:24:19 PM | Small | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $157,164,882 | EPS -$21.28 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 5/2/2026 4:05:10 AM | Small | View | Financials | 10-K/A | SEC | Y 2025 ending: 12/31/2025 | Assets $162,398,689 | EPS -$52.59 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 4/15/2026 4:25:05 PM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $162,398,689 | EPS -$52.59 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 11/14/2025 4:12:40 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $5,226,682 | EPS -$5.82 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 8/14/2025 4:36:47 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $8,266,410 | EPS -$5.13 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 7/15/2025 4:15:26 PM | View | Proxy | SEC | Y 2024 | ||||||
| Transcode Therapeutics, Inc. (RNAZ) | 5/14/2025 4:23:29 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $13,194,375 | EPS -$2.51 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 4/30/2025 4:23:57 PM | Micro | View | Financials | 10-K/A | SEC | Y 2024 ending: 12/31/2024 | Assets $7,294,499 | EPS -$47.14 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 4/15/2025 4:45:36 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $7,294,499 | EPS -$47.14 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 4/14/2025 6:05:43 AM | View | Proxy | SEC | Y 2024 | ||||||
| Transcode Therapeutics, Inc. (RNAZ) | 12/30/2024 5:08:59 PM | View | Proxy | SEC | Y 2023 | ||||||
| Transcode Therapeutics, Inc. (RNAZ) | 11/14/2024 4:41:09 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $3,936,105 | EPS -$0.16 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 10/28/2024 4:05:04 PM | View | Proxy | SEC | Y 2023 | ||||||
| Transcode Therapeutics, Inc. (RNAZ) | 8/14/2024 4:56:18 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $4,824,588 | EPS -$0.74 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 5/20/2024 4:01:32 PM | View | Proxy | SEC | Y 2023 | ||||||
| Transcode Therapeutics, Inc. (RNAZ) | 5/15/2024 4:48:36 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $7,290,467 | EPS -$0.65 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 4/29/2024 4:08:49 PM | View | Proxy | SEC | Y 2023 | ||||||
| Transcode Therapeutics, Inc. (RNAZ) | 4/5/2024 4:51:57 PM | View | Financials | Earnings | SEC | 1Q 2024 | Assets $7,290,467 | EPS -$0.65 | Export Earnings Model | ||
| Transcode Therapeutics, Inc. (RNAZ) | 4/1/2024 5:29:38 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $5,169,701 | EPS -$103.61 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 1/16/2024 4:02:30 PM | View | Financials | Earnings | SEC | Y 2023 | Assets $5,169,701 | EPS -$95.15 | Export Earnings Model | ||
| Transcode Therapeutics, Inc. (RNAZ) | 12/18/2023 4:29:21 PM | View | Proxy | SEC | Y 2022 | ||||||
| Transcode Therapeutics, Inc. (RNAZ) | 11/14/2023 9:07:54 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $10,227,846 | EPS -$1.68 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 11/14/2023 7:30:55 PM | View | Financials | Earnings | SEC | 3Q 2023 | Assets $10,227,846 | EPS -$1.68 | Export Earnings Model | ||
| Transcode Therapeutics, Inc. (RNAZ) | 10/24/2023 8:06:25 AM | View | Financials | Earnings (Prelim) | SEC | 3Q 2023 | Export Earnings Model | ||||
| Transcode Therapeutics, Inc. (RNAZ) | 10/24/2023 8:01:46 AM | View | Financials | Earnings | WIRE | 3Q 2023 | Assets $10,227,846 | EPS -$1.68 | Export Earnings Model | ||
| Transcode Therapeutics, Inc. (RNAZ) | 9/25/2023 8:31:40 AM | View | Financials | Earnings | WIRE | 2Q 2023 | Assets $5,881,545 | EPS -$142.38 | Export Earnings Model | ||
| Transcode Therapeutics, Inc. (RNAZ) | 8/14/2023 4:46:13 PM | View | Financials | Earnings | WIRE | 2Q 2023 | Assets $5,881,545 | EPS -$142.38 | Export Earnings Model | ||
| Transcode Therapeutics, Inc. (RNAZ) | 8/14/2023 4:45:20 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $5,881,545 | EPS -$142.38 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 5/15/2023 4:34:47 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $5,590,510 | EPS -$259.07 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 4/10/2023 5:02:14 PM | View | Proxy | SEC | Y 2022 | ||||||
| Transcode Therapeutics, Inc. (RNAZ) | 3/31/2023 4:22:45 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $7,587,986 | EPS -$1,082.79 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 3/31/2023 4:08:03 PM | View | Financials | Earnings | SEC | Y 2022 | Assets $7,587,986 | EPS -$1,063.63 | Export Earnings Model | ||
| Transcode Therapeutics, Inc. (RNAZ) | 2/1/2023 4:07:24 PM | View | Financials | Earnings (Prelim) | SEC | Y 2022 | Export Earnings Model | ||||
| Transcode Therapeutics, Inc. (RNAZ) | 1/31/2023 4:07:07 PM | View | Financials | Earnings | WIRE | Y 2022 | Assets $7,587,986 | EPS -$1,063.63 | Export Earnings Model | ||
| Transcode Therapeutics, Inc. (RNAZ) | 11/14/2022 4:48:43 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $12,015,573 | EPS -$6.61 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 11/14/2022 4:22:20 PM | View | Financials | Earnings | SEC | 3Q 2022 | Assets $12,015,573 | EPS -$6.61 | Export Earnings Model | ||
| Transcode Therapeutics, Inc. (RNAZ) | 8/15/2022 4:20:59 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $14,155,456 | EPS -$7.20 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 8/15/2022 4:14:03 PM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $14,155,456 | EPS -$7.20 | Export Earnings Model | ||
| Transcode Therapeutics, Inc. (RNAZ) | 5/16/2022 4:13:56 PM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $18,850,017 | EPS -$0.27 | Export Earnings Model | ||
| Transcode Therapeutics, Inc. (RNAZ) | 5/16/2022 7:16:54 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $18,850,017 | EPS -$0.27 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 5/2/2022 4:04:41 PM | View | Proxy | SEC | Y 2021 | ||||||
| Transcode Therapeutics, Inc. (RNAZ) | 4/1/2022 4:03:18 PM | View | Financials | Earnings | SEC | Y 2021 | Assets $22,938,443 | EPS -$0.23 | Export Earnings Model | ||
| Transcode Therapeutics, Inc. (RNAZ) | 3/31/2022 11:39:14 AM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $22,938,443 | EPS -$0.81 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 11/15/2021 4:13:47 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $25,359,852 | EPS -$0.20 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 11/15/2021 4:06:55 PM | View | Financials | Earnings | SEC | 3Q 2021 | Assets $25,359,852 | EPS -$0.20 | Export Earnings Model | ||
| Transcode Therapeutics, Inc. (RNAZ) | 8/23/2021 5:02:28 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $1,522,265 | EPS $0.51 | ||
| Transcode Therapeutics, Inc. (RNAZ) | 8/23/2021 4:57:25 PM | View | Earnings | SEC | 2Q 2021 | Assets $1,522,265 | EPS $0.51 |